Pacific Biosciences of California, Inc. (PACB) vs Tactile Systems Technology, Inc. (TCMD)
- Pacific Biosciences of California, Inc. PACB 2.27 −6.58%
- Tactile Systems Technology, Inc. TCMD 26.07 −1.14%
Pacific Biosciences of California, Inc. and Tactile Systems Technology, Inc. are both Medical Devices companies. Pacific Biosciences of California, Inc. is the larger, with a market value of $755.3M against $590.7M — 1.3× the size. Pacific Biosciences of California, Inc. has negative trailing earnings, so its P/E is not meaningful; Tactile Systems Technology, Inc. trades at 25.2×. Tactile Systems Technology, Inc. grew revenue faster over the last twelve months: 14.4% against 4.41%. Tactile Systems Technology, Inc. has the higher net margin (6.68% vs −81.3%) and the higher return on invested capital (15.3% vs 0.00%). Across the 16 metrics below, Tactile Systems Technology, Inc. leads on 13 and Pacific Biosciences of California, Inc. on 3.
Valuation
Profitability
| Metric | PACB | TCMD | Medical Devices median |
|---|---|---|---|
| Gross margin | 34.40% | 77.00% | 57.76% |
| Operating margin | (81.27%) | 9.44% | (15.07%) |
| Net margin | (81.31%) | 6.68% | (14.45%) |
| Free cash flow margin | (84.85%) | 8.10% | (3.88%) |
| Return on equity | 1,037.83% | 11.02% | (10.35%) |
| Return on assets | (17.22%) | 8.65% | (17.26%) |
| Return on invested capital | 0.00% | 15.33% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack